SEC Form 4 · accession 0000899243-17-027303
AVEO PHARMACEUTICALS INC · AVEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nikhil Mehta
Officer — See Remarks
Period of report
Nov 20, 2017
Accepted (ET)
Nov 22, 2017 · 4:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.09 | Nov 20, 2017 | A | 500,000 | A | — | Nov 20, 2027 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F125% of this option shall vest on November 20, 2018, and the remainder of this option shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Company.
Remarks
Senior Vice President, Regulatory Affairs and Quality Assurance